ASP Isotopes (NASDAQ:ASPI) CFO Heather Kiessling Sells 23,124 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total value of $145,218.72. Following the completion of the sale, the chief financial officer owned 1,526,252 shares in the company, valued at approximately $9,584,862.56. This trade represents a 1.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Heather Kiessling also recently made the following trade(s):

• On Wednesday, April 15th, Heather Kiessling sold 23,124 shares of ASP Isotopes stock. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52.

ASP Isotopes Stock Down 8.8%

ASP Isotopes stock traded down $0.54 during mid-day trading on Thursday, reaching $5.63. The company’s stock had a trading volume of 4,836,362 shares, compared to its average volume of 4,870,282. The company has a market capitalization of $708.82 million, a price-to-earnings ratio of -2.71 and a beta of 3.51. ASP Isotopes Inc. has a 12 month low of $3.92 and a 12 month high of $14.49. The business’s 50 day simple moving average is $6.25 and its 200 day simple moving average is $5.90. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.06. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%. The firm had revenue of $8.36 million for the quarter, compared to analysts’ expectations of $3.68 million.

Wall Street Analyst Weigh In

ASPI has been the subject of several recent research reports. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $13.00.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently added to or reduced their stakes in the business. Quantbot Technologies LP bought a new position in ASP Isotopes during the third quarter worth $34,000. BNP Paribas Financial Markets raised its position in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after purchasing an additional 2,548 shares during the period. State of Wyoming bought a new position in shares of ASP Isotopes in the first quarter valued at about $29,000. Legal & General Group Plc lifted its stake in shares of ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after buying an additional 1,953 shares during the last quarter. Finally, IFP Advisors Inc acquired a new stake in shares of ASP Isotopes during the 4th quarter worth about $48,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.